Approval · Notice of Compliance 28873 · 2022
TENOXICAM: Notice of Compliance 28873
Issued September 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28873
- Date
- September 1, 2022
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TENOXICAM | 02230661 | Dormant |
Medicinal ingredients
- TENOXICAM 20 MG per TAB